Erbitux: Demand Up, Average Wholesale Price Down (RealMoney.com $)
02:43PM 07/26/05
Antigenics' Pipeline Looks Like a No-Go (RealMoney.com $)
Oncophage is a long shot for FDA approval, and it faces steep challenges even if it gets the regulatory thumbs-up.
11:35AM 06/17/05
Antigenics' Pipeline Looks Like a No-Go
Oncophage is a long shot for FDA approval, and it faces steep challenges even if it gets the regulatory thumbs-up.
11:33AM 06/17/05
ImmunoGen Poised to Tap Growth (RealMoney.com $)
The company's cancer technology has it at a crossroads of opportunity.
10:14AM 05/31/05
Medarex Faces Post-ASCO Questions (RealMoney.com $)
The company's long-term promise remains intact, but the short-term troubles in its ASCO data raise caution flags.
03:45PM 05/17/05


Connect with TheStreet